Detalhe da pesquisa
1.
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial.
Am J Respir Crit Care Med
; 199(2): 220-231, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30092143
2.
Safety and immunogenicity of the adjunct therapeutic vaccine ID93â+âGLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.
Lancet Respir Med
; 9(4): 373-386, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306991
3.
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial.
Lancet Respir Med
; 7(9): 757-770, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416768
4.
Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of Mycobacterium tuberculosis Infection.
Front Immunol
; 9: 1529, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30013573
5.
Safety and immunogenicity of the novel tuberculosis vaccine ID93â+âGLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial.
Lancet Respir Med
; 6(4): 287-298, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29595510
6.
Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.
PLoS One
; 10(11): e0141623, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26554383
7.
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults.
Vaccine
; 33(33): 4130-40, 2015 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26095509